Eventide Asset Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-619,649
Closed -$31.6M 260
2024
Q4
$31.6M Hold
619,649
0.58% 56
2024
Q3
$25.6M Hold
619,649
0.44% 71
2024
Q2
$29.8M Sell
619,649
-505,351
-45% -$22.4M 0.51% 63
2024
Q1
$54M Buy
1,125,000
+612,086
+119% +$32.7M 0.85% 41
2023
Q4
$33.3M Hold
512,914
0.54% 58
2023
Q3
$33.5M Hold
512,914
0.6% 52
2023
Q2
$29.8M Hold
512,914
0.5% 62
2023
Q1
$31.7M Buy
512,914
+163,203
+47% +$9.79M 0.58% 58
2022
Q4
$22.2M Buy
349,711
+83,681
+31% +$6.07M 0.44% 73
2022
Q3
$19.3M Buy
266,030
+204,330
+331% +$15.2M 0.38% 76
2022
Q2
$4.2M Buy
+61,700
New +$4.43M 0.09% 122

Other funds holding NARI

Eventide Asset Management's NARI Position: Q1 2025 in Review

Eventide Asset Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 619,649 shares — an estimated $31.6M sold.

Eventide Asset Management first reported a position in NARI in Q2 2022 and held it in 11 quarters. The position peaked at $54M in Q1 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Eventide Asset Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Eventide Asset Management sold 619,649 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $31.6M.
  • Eventide Asset Management first reported a position in Inari Medical, Inc. Common Stock in Q2 2022 and held it in 11 quarters.
  • Eventide Asset Management's Inari Medical, Inc. Common Stock position peaked at $54M in Q1 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Eventide Asset Management's 13F filing for Q1 2025, filed 15 May 2025.